A. N. Rakhimov

Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K

Simone Di Giacomo, Daniele Mercatelli, A. N. Rakhimov et al. · Journal of Medical Virology · 2021 · 170 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +14

Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up

G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov et al. · Russian Journal of Cardiology · 2021 · 51 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19

G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov et al. · Russian Journal of Cardiology · 2021 · 48 citations · Full text

Medicine, Geriatric Medicine, Internal Medicine +14

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak” (AKTIV 2)

G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov et al. · Russian Journal of Cardiology · 2021 · 23 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +12

Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)

E. I. Tarlovskaya, A. G. Arutyunov, Yu. M. Lopatin et al. · Kardiologiia · 2021 · 16 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12